Dr. Meyerson is founder and Director of the Harm Reduction Research Lab which focuses on translational policy and systems science in medicine and pharmacy practice to reduce opioid overdose deaths and bloodborne illness. She leads a national team of transdisciplinary faculty from 8 U.S. universities and 1 U.S. community based organization. Dr. Meyerson leads several collaborative research teams that seek to advance harm reduction science, inspire innovative implementation science, and evolve the science of community engagement. Meyerson’s research is oriented as translational to practice and policy. Her work has informed syringe access laws in Indiana and Arizona, state policy (regulation) in Arizona for curative hepatitis C treatment and the adoption of evidence-based methadone treatment; and administrative policy in human papillomavirus vaccination in Indiana.  Recent areas of focus include the evolution of pharmacy practice to assure nonstigmatized harm reduction services such as syringe and opioid use disorder medications (MOUD) dispensing, naloxone access, and the evolution of medical practice to normalize and expand access to evidence-based MOUD treatment.